Abstract: The physiology of chondrocyte is summarized in matrix synthesis and degradation. The imbalance between the two seems to be the trigger for osteoarthritis. The end products of matrix degradation result in inflammation that will cause the release of interleukine-1 (IL-1) and tumor necrosis factor α (TNF α) by synovial cells. Non steroidal anti inflammatory drugs (NSAID) by reducing the inflammation may interfere at this level and reduce the release of ...
OUTCOME MEASUREMENT OF OCULAR LESIONS IN BEHCETS DISEASE.
Abstract: Introduction: The ocular lesions of Behcet's disease (BD) progress usually toward severe loss of vision or blindness, and therefore need aggressive treatment. However, even such a treatment is not always successful. We used classification and regression tree (cart) method to see if some factors could predict the result of the future treatment. Methods: Eight hundreds and thirty patients who fulfilled the Iran criteria for BD were selected for this study. They ...
EVALUATION OF SIL2R, ß2 MICROGLOBULIN AND TNFα HAVE A ROLE IN PATHOGENESIS OF RHUMATOID ARTHRITIS.
Abstract: Purpose: The pathogenesis of Rheumatoid Arthritis (RA) is not well understood. Looking for three mediators [Soluble Interleukine 2 Receptor (SIL2R), ß2 Microglobulin (ß2M) and Tumor Necrosis Factor α (TNF α)] in RA patients sera and synovial fluid (SF) may clear some aspects of it. Methods: The above named mediators were estimated in 72 RA patient sera and SF, 13 patient with osteoarthritis (as patient control) and 130 blood donor (as normal ...
PATHOPHYSIOLOGY OF BEHCET'S DISEASE.
Abstract: The etiology and pathogenesis of Behcet's disease (BD) are still unknown. As for other autoimmune disorders, in a special genetic background an exogenous or endogenous antigen acts as trigger in up-regulating and presenting the pathogenic epitope. The immune system reacts in an abnormal way, in the presence of a probable neuro-endocrine dysfunction(hyperprolactinemia?), by an exaggerated inflammatory response leading to the lesions of the disease. Genetic background: On the basis of chromosomal ...
COMPARISON OF POLYMYOSITIS TO POLYMYOSITIS-SCLERODERMA OVERLAP SYNDROME.
Abstract: Purpose: Polymyositis (PM) is an inflammatory muscle disease, which has more overlap with scleroderma than other connective tissue diseases. The aim of this study is to compare the clinical, paraclinical and therapeutic response of polymyositis with polymyositis-scleroderma overlap syndrome. Methods: During the past 10 years we had 16 overlap syndromes and 40 primary polymyositis. All patients were classified by the American college of Rheumatology classification criteria. Ninety-seven items were checked in ...
Treatment of Ocular Manifestations of Behcet's Disease.
Abstract: Purpose: Ocular lesions are the major cause of morbidity in Behcet's Disease. Cytotoxic drugs are the main therapeutic agents. We present here a comparative study of 8 methods in 1056 treated cases. Materials & Methods: In an open, nonrandomized control study, Pulse Cyclophosphamide (PCP), low dose PCP (LDP), oral Cyclophosphamide (OCP), weakly methotrexate (MTX), chlorambucil (CHL), cyclosporine A (CYA), azathioprine (AZA), and combination therapy with LDP and MTX (COM) were used ...
APLAR EVALUATION OF BEHCET'S DISEASE DIAGNOSTIC CRITERIA.
Abstract: INTRODUCTION: There are six sets of diagnosis criteria for Behcet's Disease (BD). There is yet no general agreement on which one to use. The International criteria was created to bring this agreement. The aim of this study was to evaluate these criteria, especially the performance of the International criteria. MATERIALS and METHODS: Three countries (China, Iran and Korea) participated in the study. In each country, BD patients were selected as every ...
Outcome of Patients With Ocular Lesions of Behcet's Disease (BD) Non Responding to Classical Treatments.
Abstract: Introduction: We reported last year, during the ACR annual meeting, the result of different treatment modalities for ocular lesions of BD in 856 patients. We showed that pulse cyclophosphamide (PCP), low dose pulse cyclophosphamide (LDP), oral cyclophosphamide (OCP), weakly methotrexate (MTX), chloambucil (CHL), and cyclosparine A (CYA) had all the same efficacy. The percentage of the eyes aggravated (visual acuity) despite the treatment was: For PCP: 21%, LDP: 22%, OCP: ...
Polymyositis in Iranian children, analysis of 47 cases.
Abstract: Aim: The aim of this study was to assess the demography of polymyositis in Iranian children. Methods: 47 children classified by the ACR Criteria as having polymyositis were studied. 95 items were checked for every patient. They were followed regularly and the data were updated at each visit. Results: Thirty patients were female (64%). The acute presentation of the disease was seen in 10%. The manifestations at the onset of ...
Scleroderma in Iranian children.
Abstract: Scleroderma may occur in childhood with different characteristics. The present study shows the picture of scleroderma in Iranian children and compares the characteristics in children and adults. Methods: 56 scleroderma patients under 16 were compared with 217 adult scleroderma seen since 1975. Data were compared with Chi square test. Results: Girls were 44 (79%) and boys 12. The initial presentation was: Raynaud's phenomenon 68%, skin edema 27%, limb skin sclerosis 66%, ...